DoW Peer Reviewed Medical, Platform Clinical Translation Award
About
Summary: The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Platform Clinical Translation Award supports the translational development and/or early-phase clinical trials for broadly applicable clinical technologies that will address urgent and complex needs related to two congressionally directed FY26 PRMRP topic areas. The platform product in development should address one of the FY26 PRMRP portfolio-specific strategic goals and address the health care needs of military Service Members, Veterans and their Families. Distinctive Features: Allows for multiple Principal Investigators (PIs). The proposed experiments may represent a single project led by a single PI, or it may consist of partnerships between principal investigators that will occur synergistically to advance a platform product. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. Up to two additional PIs can be identified as Partnering PIs. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). Requires a PI-convened external advisory board with patient advocate participation. The patient advocate must be a person living with, or a family member or caretaker of someone with, a disease or condition addressed in one of the applicant-selected congressionally directed FY26 PRMRP topic areas. Funding Details: The Congressionally Directed Medical Re.
The DoW Peer Reviewed Medical, Platform Clinical Translation Award supports organizations and research teams developing clinical technologies that address urgent healthcare needs for military Service Members, Veterans, and their families. This grant funds the translational development and early-phase clinical trials of broadly applicable platform products aligned with congressionally directed FY26 PRMRP topic areas. The award is designed for researchers and organizations ready to move promising medical innovations from the laboratory into clinical practice. Applicants can submit proposals as a single PI or through multi-PI partnerships, with up to three Principal Investigators collaborating on a single project. A distinctive requirement includes establishing an external advisory board with patient advocate participation, ensuring that individuals living with or affected by the targeted condition have a voice in the research direction. This grant represents a significant opportunity for medical researchers, biotech entrepreneurs, and clinical development teams seeking federal funding to advance healthcare solutions for the military and veteran population. If you're developing a clinical technology with broad applications that serves this underserved population, this award can provide the resources needed to conduct critical translational research and early-phase trials.
Funding Facts
● Applications openDeadline
September 22, 2026
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle and project scope
Deadline
2026-09-22
Grant Type
federal
Application Cycle
Annual (FY26 deadline: September 22, 2026)
Best For
Medical researchers, clinical development teams, and institutions advancing translational research for military Service Members and Veterans
Frequently Asked Questions
Who is eligible for DoW Peer Reviewed Medical, Platform Clinical Translation Award?
Specific eligibility criteria are not detailed in the available information. Applicants should visit the official Department of Defense or PRMRP website for complete eligibility requirements, including institutional qualifications, PI credentials, and organizational requirements. Generally, research institutions, universities, and medical organizations may be eligible, but verification is essential.
How much funding does DoW Peer Reviewed Medical, Platform Clinical Translation Award provide?
Specific funding amounts are not specified in the available program details. Award amounts vary by cycle and project scope. Applicants should consult the official solicitation on the Department of Defense website or the PRMRP program page for current funding ranges and budget limitations for FY26.
How do I apply for DoW Peer Reviewed Medical, Platform Clinical Translation Award?
Applications are submitted through the Department of Defense's official grants portal. The deadline for FY26 submissions is September 22, 2026. Applicants must designate an Initiating PI responsible for administrative submission tasks and may include up to two additional Partnering PIs. A patient-advocate-inclusive external advisory board is required as part of the application package. Consult the official DoD PRMRP website for detailed submission instructions, required documentation, and specific formatting requirements.
What can DoW Peer Reviewed Medical, Platform Clinical Translation Award funding be used for?
Funding supports translational development and early-phase clinical trials for broadly applicable clinical technologies. Projects must address one of the congressionally directed FY26 PRMRP topic areas and serve the healthcare needs of military Service Members, Veterans, and their families. The platform product should represent a synergistic research effort designed to move innovative technologies from development toward clinical implementation.
Last updated: July 5, 2026